NAMI Ask the Expert: A Fireside Chat with Dr. Marlene Freeman and Dr. Ken Duckworth
Dr. Marlene Freeman recently shared her insights on Psychiatric Medications and Considerations for Individuals Across Pregnancy, the Postpartum, and Reproductive Years with the National Alliance on Mental Illness on March 7, 2024.
Which is Safer for the Treatment of Opioid Use Disorder During Pregnancy: Buprenorphine or Methadone?
In this large cohort study analyzing data from publicly insured Medicaid beneficiaries, the overall risk of malformations was lower with buprenorphine than with methadone.
Depression During Pregnancy Is a Risk Factor for Postpartum Depression, Does Timing Matter?
Women who experienced depression during pregnancy were about four times as likely to experience PPD compared to women with no depression during pregnancy, with greater risk associated with depression during the first and third trimesters.
We anticipate finishing production in the late spring of 2024. We look forward to sharing more information with you in the months to come.
Interested in participating in future research at the CWMH? You are invited to complete our interest form.